We read with great interest the recent article by Verweij et al. 1 The authors ascribe the beneficial effects of preoperative fasting in reducing liver ischemia/reperfusion injury to the induction of heme oxygenase 1 and various antioxidants, including superoxide dismutase 2, glutathione peroxidase
HIP/PAP accelerates liver regeneration and protects against acetaminophen injury in mice
✍ Scribed by Hanh-Tu Lieu; Frédéric Batteux; Marie-Thérèse Simon; Alexandre Cortes; Carole Nicco; Flora Zavala; Alain Pauloin; José Guilherme Tralhao; Olivier Soubrane; Bernard Weill; Christian Bréchot; Laurence Christa
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 508 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Human hepatocarcinoma-intestine-pancreas/pancreatic-associated protein HIP/PAP is a secreted C-type lectin belonging to group VII, according to Drickamer's classification. HIP/PAP is overexpressed in liver carcinoma; however, its functional role remains unclear. In this study, we demonstrate that HIP/PAP is a paracrine hepatic growth factor promoting both proliferation and viability of liver cells in vivo. First, a low number of implanted hepatocytes deriving from HIP/PAP-transgenic mice (<1:1,000) was sufficient to stimulate overall recipient severe combined immunodeficiency liver regeneration after partial hepatectomy. After a single injection of HIP/PAP protein, the percentages of bromodeoxyuridine-positive nuclei and mitosis were statistically higher than after saline injection, indicating that HIP/PAP acts as a paracrine mitogenic growth factor for the liver. Comparison of the early events posthepatectomy in control and transgenic mice indicated that HIP/PAP accelerates the accumulation/degradation of nuclear phospho-signal transducer activator transcription factor 3 and tumor necrosis factor ␣ level, thus reflecting that HIP/PAP accelerates liver regeneration. Second, we showed that 80% of the HIP/PAP-transgenic mice versus 25% of the control mice were protected against lethal acetaminophen-induced fulminate hepatitis. A single injection of recombinant HIP/PAP induced a similar cytoprotective effect, demonstrating the antiapoptotic effect of HIP/PAP. Comparison of Cu/Zn superoxide dismutase activity and glutathione reductase-like effects in control and transgenic liver mice indicated that HIP/PAP exerts an antioxidant activity and prevents reactive oxygen species-induced mitochondrial damage by acetaminophen overdose. In conclusion, the present data offer new insights into the biological functions of C-type lectins. In addition, HIP/PAP is a promising candidate for the prevention and treatment of liver failure. (HEPATOLOGY 2005;42:618-626.)
C
-type lectins are cation-dependent carbohydratebinding proteins with a common carbohydrate recognition domain of 115-130 amino acid residues. 1 These proteins exhibit various functions such as complement activation, 2 endocytosis, 3 cell recognition, 4 and morphogenesis. 5 It has been recently reported that the viral EP153R protein is endowed with antiapoptotic properties in vitro, which is unexpected for a C-type lectin. 6 The hepatocarcinoma-intestine-pancreas/pancreaticassociated protein (HIP/PAP) is a human 16-kd secreted protein whose complementary DNA has been cloned in humans 7,8 as well as rats, mice, and hamsters under the names PAPI or peptide 23, Reg-2 or RegIII, and IN-GAP, 9 respectively. The HIP/PAP and the lithostatine/ RegI-related genes are classified in group VII of the C-type lectin gene superfamily and encode small secreted proteins with a single carbohydrate recognition domain linked to a signal peptide. 1,10 Because the physiological functions of group VII lectins remain unclear, structurefunction relationships are difficult to establish. The human HIP/PAP protein has been shown to bind lactose, 11
📜 SIMILAR VOLUMES
We show that brief periods of fasting induce functional changes similar to those induced by long-term dietary restriction in mice, and these changes include protection from ischemia/reperfusion (I/R) injury. In this study, we investigated the mechanisms of protection induced by fasting, and we deter
Our previous study demonstrated that polycationic liposomes are highly stable in the bloodstream and represent an effective agent for liver gene delivery. We report here that liposomemediated extracellular superoxide dismutase (EC-SOD) gene delivery successfully prevented acute liver injury in mice.
Hepatic ischemia/reperfusion (I/R) injury is characterized by the generation of reactive oxygen species (ROS), such as superoxide anions and hydrogen peroxide. The aim of this study is to investigate whether antioxidative gene delivery by our polylipid nanoparticles (PLNP) is an effective approach f
Prostaglandin E series (PGEs) are known to protect against lipopolysaccharide (LPS)-induced liver injury by down-regulating the production of inflammatory cytokines. We show here a novel mechanism whereby prostaglandin E 1 protects mice against liver injury after Escherichia coli infection. Prostagl